Merck operates as a multinational pharmaceutical company, while Verona Pharma plc focuses on developing biopharmaceuticals specifically for respiratory diseases.
Merck plans to acquire Verona Pharma for approximately $10 billion USD
Jul 9, 2025
Jul 9, 2025
Merck operates as a multinational pharmaceutical company, while Verona Pharma plc focuses on developing biopharmaceuticals specifically for respiratory diseases.
Economists are at work to possibly explain antitrust and competition matters.